Bgm (BGM) Current Deferred Revenue (2019 - 2026)
Bgm's Current Deferred Revenue came in at $1.74 million for fiscal Q2 2026 (quarter ended Mar 31, 2026), down 49.8% from $3.47 million a year earlier.
Powered by 
Analysis
Bgm (BGM) Current Deferred Revenue (2019 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Bgm's Current Deferred Revenue was $1.37 million, up 179.6% from FY2024.
- Current Deferred Revenue carries a five-year compound annual growth rate of -17.2% (FY2020 to FY2025).
- Going back by fiscal year, Current Deferred Revenue was $489,784 in FY2024 (-52.4%), $1.03 million in FY2023 (+84.8%), $556,418 in FY2022 (-77.4%) and $2.47 million in FY2021 (-29.7%).
- The five-year range for quarterly Current Deferred Revenue is $392,518 (fiscal Q2 2024) to $3.47 million (fiscal Q2 2025).
- Year-over-year, Current Deferred Revenue increased in two of the last four quarters, with growth averaging 215.4%.
- The fastest year-over-year change in Current Deferred Revenue over five years came in fiscal Q2 2025 (growth of 784.3%), and the weakest in fiscal Q2 2024 (a decline of 84.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bgm | 28.32 Mn | -4,800.01 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.74 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Sep 30, 2024 | 489,784.00 |
| Mar 31, 2024 | 392,518.00 |
| Sep 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 2.48 Mn |
| Sep 30, 2022 | 556,418.00 |
| Mar 31, 2022 | 3.23 Mn |
| Sep 30, 2021 | 2.47 Mn |
| Sep 30, 2020 | 3.51 Mn |
| Sep 30, 2019 | 1.91 Mn |
API Access
Bgm Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BGM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "BGM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BGM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();